Delivery Order SPE2DB24D1034-SPE2DB25FWFH0
- Not listed
- The Defense Logistics Agency (DLA) awarded a $14,019.04 delivery order to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 26, 2025, with completion targeted for September 29, 2025. This firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The award was competitively awarded with no set-aside...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for 90 tablets of Januvia 100 mg on September 10, 2025, with an ultimate completion date of September 11, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a pharmaceutical supply delivery to support federal medical procurement needs. The contract is issued as a child order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,273.37 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count) on June 24, 2025, with an ultimate completion date of June 25, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award and serves as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of 1,000 tablets of Januvia 100 mg, with a contract ceiling value of $50,372.45 and a firm fixed-price structure. This is a non-set-aside, competitively awarded delivery order with an ultimate completion date of September 2, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a...
- The Defense Logistics Agency awarded a $2,717.61 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price contract, which is a child award under a larger indefinite delivery vehicle, represents a competitively awarded non-set-aside delivery order with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $15,034.57 delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Januvia 100 mg tablets (90-count units). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of July 30, 2025, and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and...
- The Defense Logistics Agency awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count packages) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,881.99 to AmerisourceBergen Drug Corp for the supply of Januvia 50 mg tablets (90-count units) on July 10, 2025, with an ultimate completion date of July 11, 2025. This firm fixed-price delivery order represents a non-competitive award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion pharmaceutical supply agreement running through December 2026. The...
- The Defense Logistics Agency awarded a $3,683.24 delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Januvia 100 mg tablets (90-count) under a firm fixed-price contract. The order, which has an ultimate completion date of July 25, 2025, will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was competitively procured with no set-aside designation and operates as a child contract under a larger vehicle. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Januvia 100 mg tablets (90-count packages) under a firm fixed-price contract with a ceiling value of $3.9K. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1B global pharmaceutical support vehicle running through December 2026. The award was made through open...
- SPE2DB24D1034Indefinite Delivery Contract
- SPE2DB24D1034-SPE2DB25FWFH0Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,182.92 to AmerisourceBergen Drug Corp for the supply of Januvia 100 mg tablets (90-count units). This firm fixed-price, competitively awarded delivery order was issued on August 26, 2025, with an ultimate completion date of August 27, 2025. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen is a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, and serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order falls within the scope of DLA's pharmaceutical supply chain operations, which leverage AmerisourceBergen's comprehensive portfolio of brand-name and generic medications to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award of Januvia, an established diabetes management medication, reflects the ongoing medical supply needs across the federal healthcare network. As a non-set-aside award, this contract was competitively awarded, demonstrating AmerisourceBergen's continued capability to meet federal procurement requirements and support military personnel and beneficiaries with essential pharmaceutical products.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 8/26/25 |